KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ichor Holdings (ICHR) Cash & Equivalents (2016 - 2026)

Ichor Holdings has reported Cash & Equivalents over the past 11 years, most recently at $89.1 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 18.48% to $89.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $89.1 million through Mar 2026, down 18.48% year-over-year, with the annual reading at $98.3 million for FY2025, 9.55% down from the prior year.
  • Cash & Equivalents was $89.1 million for Q1 2026 at Ichor Holdings, down from $98.3 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $116.4 million in Q3 2024 and troughed at $56.5 million in Q3 2022.
  • The 5-year median for Cash & Equivalents is $92.2 million (2025), against an average of $91.7 million.
  • Year-over-year, Cash & Equivalents plummeted 55.9% in 2022 and then surged 53.35% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $86.5 million in 2022, then fell by 7.53% to $80.0 million in 2023, then soared by 35.91% to $108.7 million in 2024, then dropped by 9.55% to $98.3 million in 2025, then dropped by 9.36% to $89.1 million in 2026.
  • Per Business Quant, the three most recent readings for ICHR's Cash & Equivalents are $89.1 million (Q1 2026), $98.3 million (Q4 2025), and $92.5 million (Q3 2025).